We are live on ! Find out more
AA

AQR Arbitrage Portfolio holdings

AUM $6.09B
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.78B
AUM Growth
-$65.9M
Cap. Flow
-$1.1B
Cap. Flow %
-39.55%
Top 10 Hldgs %
16.2%
Holding
1,575
New
503
Increased
22
Reduced
219
Closed
602

Sector Composition

Rank Sector Weight
1 Financials 10.51%
2 Healthcare 6.47%
3 Industrials 4.82%
4 Consumer Discretionary 4.5%
5 Technology 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNRHW
776
DELISTED
Senior Connect Acquisition Corp. I Warrant
SNRHW
$71K ﹤0.01%
+99,999
New +$118K
TEKKW
777
DELISTED
Tekkorp Digital Acquisition Corp. Warrant
TEKKW
$71K ﹤0.01%
+75,000
New +$124K
ATAC.WS
778
DELISTED
Altimar Acquisition Corp Warrants
ATAC.WS
$70K ﹤0.01%
49,999
PMGMW
779
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$69K ﹤0.01%
+119,166
New +$87.7K
EPHYW
780
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$69K ﹤0.01%
+83,332
New +$87.7K
SKINW
781
DELISTED
The Beauty Health Company Warrant expiring 5/4/2026
SKINW
$69K ﹤0.01%
33,333
BREZW
782
DELISTED
Breeze Holdings Acquisition Corp. Warrant
BREZW
$68K ﹤0.01%
100,000
PHICW
783
DELISTED
Population Health Investment Co., Inc. Warrant
PHICW
$66K ﹤0.01%
+62,444
New +$105K
NBA.WS
784
DELISTED
New Beginnings Acquisition Corp. Redeemable Warrants, each warrant exercisable for one share of Comm
NBA.WS
$66K ﹤0.01%
100,000
CXAIW icon
785
CXApp Inc Warrant
CXAIW
$1.01M
$65K ﹤0.01%
+99,999
New +$121K
GRCYW
786
DELISTED
Greencity Acquisition Corporation Warrants
GRCYW
$65K ﹤0.01%
150,000
CRU.WS
787
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$65K ﹤0.01%
+46,965
New +$73.4K
RSVRW icon
788
Reservoir Media Inc Warrant
RSVRW
$64K ﹤0.01%
+50,000
New +$91.5K
LEGOW
789
DELISTED
Legato Merger Corp. Warrant
LEGOW
$63K ﹤0.01%
+132,000
New +$74.9K
AJAX.WS
790
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
$63K ﹤0.01%
+37,500
New +$111K
GFX.WS
791
DELISTED
Golden Falcon Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
GFX.WS
$62K ﹤0.01%
+87,500
New +$112K
OTRAW
792
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$61K ﹤0.01%
99,999
CTAC.WS
793
DELISTED
Cerberus Telecom Acquisition Corp. Warrants included as part of the Units, each whole warrant exerci
CTAC.WS
$61K ﹤0.01%
58,332
ADVWW
794
DELISTED
Advantage Solutions Warrant
ADVWW
$60K ﹤0.01%
18,750
SVSVW
795
DELISTED
Spring Valley Acquisition Corp. Warrant
SVSVW
$59K ﹤0.01%
49,999
CEREW
796
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$57K ﹤0.01%
13,333
COEPW
797
DELISTED
Coeptis Therapeutics Warrants
COEPW
$56K ﹤0.01%
+130,000
New +$122K
MEUSW
798
DELISTED
23andMe Holding Co Warrant
MEUSW
$56K ﹤0.01%
33,333
GSAH.WS
799
DELISTED
GS Acquisition Holdings Corp II Redeemable Warrants, each whole warrant exercisable for one share of
GSAH.WS
$55K ﹤0.01%
25,000
STRDW
800
DELISTED
Sitio Royalties Corp. Warrant
STRDW
$54K ﹤0.01%
222,879

Similar funds

AQR Arbitrage's Q1 2021 Portfolio in Review

As of Q1 2021, AQR Arbitrage held 1,575 positions worth $2.78B, down 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AQR Arbitrage withdrew a net $1.1B in Q1 2021, closing 602 positions and reducing 219 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AQR Arbitrage opened a new position in Cantel Medical Corporation worth $33.4M.

  • AQR Arbitrage's largest Q1 2021 buy was Cantel Medical Corporation: 420,838 shares worth $33.4M.
  • AQR Arbitrage added most to PRA Health Sciences, Inc. in Q1 2021, an estimated $23.3M increase.
  • AQR Arbitrage's biggest Q1 2021 reduction was International Flavors & Fragrances Inc. 6.00% Tangible Equity Units, cutting an estimated $12.5M.
  • AQR Arbitrage fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $36.2M.
  • AQR Arbitrage's ten largest holdings make up 16% of its $2.78B portfolio in Q1 2021.
  • AQR Arbitrage opened 503 new positions and closed 602 in Q1 2021.
  • AQR Arbitrage's portfolio value fell 2.3% quarter-over-quarter to $2.78B.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.